Prothena Corporation plc

NASDAQ:PRTA   3:59:51 PM EDT
29.64
+1.75 (+6.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.39B
Current PE20.55
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$17.18 Million
Adjusted EPS-$0.52
See more estimates
10-Day MA$27.29
50-Day MA$27.17
200-Day MA$42.02
See more pivots

Prothena Corporation plc Stock, NASDAQ:PRTA

77 Sir John Rogersons Quay, Grand Canal Docklands, Dun Laoghaire, Dublin 2
Ireland
Phone: +353.1.236.2500
Number of Employees: 82

Description

Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firm�s clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer�s disease, Parkinson�s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.